Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Calyxt Inc (CLXT)

Calyxt Inc (CLXT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 187,491
  • Shares Outstanding, K 32,951
  • Annual Sales, $ 240 K
  • Annual Income, $ -27,900 K
  • 60-Month Beta 2.64
  • Price/Sales 52.67
  • Price/Cash Flow N/A
  • Price/Book 2.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.39
  • Number of Estimates 1
  • High Estimate -0.39
  • Low Estimate -0.39
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.54 +2.71%
on 01/24/20
8.27 -31.20%
on 01/15/20
-0.78 (-12.06%)
since 12/24/19
3-Month
3.55 +60.28%
on 11/29/19
8.27 -31.20%
on 01/15/20
+0.93 (+19.54%)
since 10/24/19
52-Week
3.55 +60.28%
on 11/29/19
19.30 -70.51%
on 03/20/19
-5.88 (-50.82%)
since 01/24/19

Most Recent Stories

More News
Calyxt Appoints Bobby Williams as Gene Editing Director to Expand Innovation and Product Pipeline

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has appointed Bobby Williams, Ph.D. to the newly created role of Director of Gene Editing to further expand Calyxt's innovation, product pipeline,...

CLXT : 5.69 (-4.05%)
Calyxt Issues Stockholder Letter

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has released the following letter to its stockholders from Jim Blome, Chief Executive Officer.

CLXT : 5.69 (-4.05%)
Calyxt Announces Collaboration with Central Valley Ag to Expand Grower Network

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has entered into a collaboration with Central Valley Ag (CVA) Cooperative, a leading provider of products...

CLXT : 5.69 (-4.05%)
Calyxt Appoints Vince Restucci as Vice President of Agronomy Services to Accelerate Expansion

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has appointed Vince Restucci in a newly created role as Vice President of Agronomy Services to support...

CLXT : 5.69 (-4.05%)
Calyxt to Participate at Upcoming Investor Conferences

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has been invited to participate in the following investor conferences during the months of November and...

MS : 54.55 (-1.76%)
CLXT : 5.69 (-4.05%)
Calyxt Reports Record Third Quarter 2019 Financial Results

--Reiterates 2019 Annual Revenue Guidance of $7 Million to $8 Million

CLXT : 5.69 (-4.05%)
Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the...

CLXT : 5.69 (-4.05%)
Calyxt Provides Business and R&D Pipeline Update at Wells Fargo Consumer Conference

--Six New Products in R&D Pipeline

CLXT : 5.69 (-4.05%)
Calyxt(R) Announces Seed Agreement with Landus Cooperative

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced that the Company has expanded its geographic footprint for acreage growth and weather-risk diversity by adding Landus Cooperative's...

CLXT : 5.69 (-4.05%)
Calyxt(R) to Present at the Fall Investor Summit on September 17, 2019

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, today announced that management plans to present at the Fall Investor Summit in New York City.

CLXT : 5.69 (-4.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade CLXT with:

Business Summary

Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United...

See More

Key Turning Points

2nd Resistance Point 6.20
1st Resistance Point 5.95
Last Price 5.69
1st Support Level 5.49
2nd Support Level 5.28

See More

52-Week High 19.30
Fibonacci 61.8% 13.28
Fibonacci 50% 11.42
Fibonacci 38.2% 9.56
Last Price 5.69
52-Week Low 3.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar